Quidel is a longstanding entity in the biotechnology and healthcare sectors, founded in 1979 and headquartered in the United States. With a focus on developing and manufacturing intelligent diagnostic solutions, QuidelOrtho is dedicated to transforming data into actionable insights, enhancing early trend detection, and providing decisive and accurate analysis for global health improvement.
This company operates at the intersection of Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries, positioning itself as a critical player in advancing diagnostics for a healthier future. Their innovative solutions cater to diverse markets and contribute significantly to efficient healthcare delivery systems.
The most recent financial boost was a $630.00K grant investment received on 01 May 2020, highlighting a favorable reception of its strategic initiatives. This financial backing underscores its reputation and potential for sustainable growth in the rapidly evolving healthcare landscape.